By Zeke Miller and Darlene Superville 

Updated 6:10 pm ET

President Donald Trump said Monday that he is taking a malaria drug to protect against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects.

Trump told reporters he has been taking the drug, hydroxychloroquine, and a zinc supplement daily “for about a week and a half now.” Trump spent weeks pushing the drug as a potential cure or prophylaxis for COVID-19 against the cautionary advice of many of his administration's top medical professionals. The drug has the potential to cause significant side effects in some patients and has not been shown to combat the new coronavirus.

Trump said his doctor did not recommend the drug to him, but he requested it from the White House physician.

"I started taking it, because I think it’s good," Trump said. "I’ve heard a lot of good stories.”

The Food and Drug Administration warned health professionals last month that the drug should not be used to treat COVID-19 outside of hospital or research settings, due to sometimes fatal side effects. Regulators issued the alert for the drug, which can also be used to treat lupus and arthritis, after receiving reports of heart-rhythm problems, including deaths, from poison control centers and other health providers.

Trump dismissed reports of side effects, saying, “All I can tell you is, so far I seem to be OK.”

At least two White House staffers tested positive for COVID-19 earlier this month, sparking concerns about the steps taken by the administration to protect the president and sending Vice President Mike Pence and other officials into varying forms of self-isolation.

The White House has since mandated that those in the West Wing wear face coverings and has introduced daily testing for the virus for the president, vice president, and those they come in close contact with.

Trump last underwent an “interim” checkup in a November visit to Walter Reed National Military Medical Center that was not noted on his public schedule. His last complete physical took place in February 2019.

Trump has repeatedly pushed the use of the drug with or without the antibiotic azithromycin, but no large, rigorous studies have found them safe or effective for preventing or treating COVID-19.

Two large observational studies, each involving around 1,400 patients in New York, recently found no benefit from hydroxychloroquine. Two new ones published Thursday in the medical journal BMJ reached the same conclusion.

One, by French researchers, gave 84 hospitalized patients the drug and 97 others the usual care. There were no differences in the odds of death, need for intensive care or developing severe illness.

The other study from China was a stricter test: 150 adults hospitalized with mild or moderate illness were randomly assigned to get hydroxychloroquine or usual care. The drug made no difference in rates of clearing the virus or time to relief of symptoms, and they brought more side effects.

In April, the National Institutes of Health launched a study testing hydroxychloroquine versus a placebo drug in 500 hospitalized COVID-19 patients. Last week, NIH announced another study to see if hydroxychloroquine plus azithromycin can prevent hospitalization or death in people with mild to moderate illness. About 2,000 U.S. adults with confirmed coronavirus infections and symptoms such as fever, cough, or shortness of breath will get the drugs or placebo pills.

U.S. prescriptions for hydroxychloroquine surged roughly 80% in March to more than 830,000 compared with the same period in the prior year, according to data tracking firm IQVIA. That jump in prescribing came before the federal government accepted nearly 30 million doses of the drug donated to the strategic national stockpile by foreign drugmakers. Since then, millions of those tablets have been shipped to U.S. hospitals nationwide for use treating patients with COVID-19.

—-

AP medical writers Marilynn Marchione in Milwaukee and Matthew Perrone in Washington contributed to this report.

Share:
More In Politics
Biden, Putin Chat as Russian Troops Mass on Ukraine Border
President Biden spoke with Russian President Vladimir Putin for the fourth time this year. Biden and Putin spoke for two hours about the massing of Russian troops and materials near the Russian border with Ukraine. Various outlets have reported that the U.S. has intelligence that Russia could be planning an invasion of Ukraine in the next few months. Both countries said the call was productive, but the situation remains tense. Hagar Chemali, foreign policy expert and host of "Oh My World!" on YouTube, joins Cheddar Politics to discuss.
What Hispanic Voters Are Looking for as Poll Shows Even Split Between Parties
A recent Wall Street Journal poll indicated that Hispanic voters are up for grabs for the upcoming midterm elections, with 41 percent of respondents saying they would vote for Democrats and 44 percent for Republicans. Bryanta "Bre" Maxwell, a Democratic Strategist, former political director for Jaime Harrison's senate campaign, and principal and CEO of Indigo Consulting, LLC, joined Cheddar to break down the numbers and to dive into what this specific electorate is looking for as the balance of power in Congress hangs in the balance in 2022.
Is VP Harris Getting Sidelined?
Vice President Kamala Harris received impressive amount of media coverage in January for making history. However, the media attention waned significantly and some are now even saying she has almost disappeared from public view. Reecie Colbert, founder of BlackWomenViews Media, joined Cheddar Politics to discuss more.
Buzzfeed Scores Win in Mueller Report FOIA Fight
If you thought you heard the last of the Mueller report back in 2019, you'd be wrong. While the bombshell report was the biggest story in Washington for years, much of the report remained redacted. Our friends at BuzzFeed News weren't satisfied, so they sued to have certain passages unredacted. They notched another win when a federal appeals court ordered ten passages from the report to be released. Matt Topic, BuzzFeed's attorney in the case, and Jason Leopold, reporter at BuzzFeed News, join Cheddar Politics to discuss.
Omicron Spotlights Lack of Global Pandemic Preparedness
The U.S. reported its first confirmed case of the omicron variant in California on Wednesday. Scientists and health officials are racing to understand the variant, with the WHO saying it's still too early to determine whether it's more contagious, more deadly or more resistant to vaccines than other variants. Omicron has pushed members of the WHO to commit to start talks over a "gobal pandemic treaty" for future pandemic preparedness. Priti Krishtel, co-founder and co-executive director of the Initiative for Medicines, Access & Knowledge, joins Cheddar Politics to discuss.
Roe v. Wade at Stake After Supreme Court Mississippi Abortion Hearing
Wednesday was not a good day for those who believe in abortion rights in this country as the Supreme Court heard arguments on a Mississippi abortion law that bans most abortions after 15 weeks of pregnancy. The majority of the court appears poised to roll back abortion rights, and the questions from the conservative justices seemed to indicate the law for nearly 50 years is likely to change. Jessica Mason Pieklo, senior vice president and executive editor of Rewire News Group, joined Cheddar Politics to discuss Wednesday's hearing.
Michael Cohen to Sell His Federal Prison Badge as NFT
Michael Cohen, Donald Trump's former personal lawyer, has been busy since completing his prison sentence in November. He's getting into the NFT space, selling his federal prison badge and the original manuscript of his book "Disloyal" as NFTs. Cohen joined Cheddar to discuss his latest venture and why he thinks there is still much to be revealed about his case.
Load More